Fulgent Genetics Operating Margin 2015-2024 | FLGT

Current and historical operating margin for Fulgent Genetics (FLGT) over the last 10 years. The current operating profit margin for Fulgent Genetics as of December 31, 2024 is -9.46%.
Fulgent Genetics Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-12-31 $0.28B $-0.07B -26.15%
2024-09-30 $0.28B $-0.21B -75.18%
2024-06-30 $0.29B $-0.19B -65.98%
2024-03-31 $0.29B $-0.19B -67.01%
2023-12-31 $0.29B $-0.20B -67.59%
2023-09-30 $0.29B $-0.08B -28.57%
2023-06-30 $0.31B $-0.08B -26.62%
2023-03-31 $0.37B $-0.05B -13.42%
2022-12-31 $0.62B $0.18B 28.76%
2022-09-30 $0.80B $0.37B 45.58%
2022-06-30 $0.93B $0.53B 56.76%
2022-03-31 $0.95B $0.61B 64.05%
2021-12-31 $0.99B $0.68B 68.08%
2021-09-30 $1.04B $0.75B 72.49%
2021-06-30 $0.91B $0.66B 72.09%
2021-03-31 $0.77B $0.56B 72.45%
2020-12-31 $0.42B $0.29B 68.96%
2020-09-30 $0.14B $0.07B 48.15%
2020-06-30 $0.04B $0.00B 6.98%
2020-03-31 $0.03B 0 0.00%
2019-12-31 $0.03B 0 0.00%
2019-09-30 $0.03B $0.00B -3.45%
2019-06-30 $0.03B $0.00B -16.00%
2019-03-31 $0.02B $-0.01B -22.73%
2018-12-31 $0.02B $-0.01B -22.73%
2018-09-30 $0.02B $-0.01B -30.00%
2018-06-30 $0.02B $-0.01B -31.58%
2018-03-31 $0.02B $-0.01B -26.32%
2017-12-31 $0.02B $0.00B -15.79%
2017-09-30 $0.02B 0 0.00%
2017-06-30 $0.02B 0 0.00%
2017-03-31 $0.02B $0.00B 5.00%
2016-12-31 $0.02B 0 0.00%
2016-06-30 $0.01B $0.00B 10.00%
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $0.532B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $37.757B 52.15
Tempus AI (TEM) US $8.929B 0.00
Hims & Hers Health (HIMS) US $8.034B 129.14
Inspire Medical Systems (INSP) US $4.699B 91.27
IRhythm Technologies (IRTC) US $3.466B 0.00
Privia Health (PRVA) US $2.778B 208.18
Enovis (ENOV) US $1.976B 12.23
Schrodinger (SDGR) US $1.817B 0.00
Clover Health Investments (CLOV) US $1.696B 0.00
Phreesia (PHR) US $1.483B 0.00
Omnicell (OMCL) US $1.470B 31.70
Azenta (AZTA) US $1.199B 55.81
10x Genomics (TXG) US $0.991B 0.00
Butterfly Network (BFLY) US $0.568B 0.00
Talkspace (TALK) US $0.527B 313.00
Veradigm (MDRX) US $0.476B 0.00
Standard BioTools (LAB) US $0.422B 0.00
TruBridge (TBRG) US $0.390B 0.00
Claritev (CTEV) US $0.360B 0.00
Health Catalyst (HCAT) US $0.280B 0.00
Nyxoah SA (NYXH) BE $0.205B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.201B 0.00
Pulmonx (LUNG) US $0.152B 0.00
American Well (AMWL) US $0.097B 0.00
EUDA Health Holdings (EUDA) SG $0.091B 0.00
Retrieve Medical Holdings (RMHI) US $0.085B 0.00
MDxHealth SA (MDXH) BE $0.082B 0.00
CareCloud (CCLD) US $0.075B 3.24
111 (YI) CN $0.071B 0.00
P3 Health Partners (PIII) US $0.064B 0.00
HeartBeam (BEAT) US $0.059B 0.00
Zepp Health (ZEPP) CN $0.041B 0.00
Outset Medical (OM) US $0.040B 0.00
Zhongchao (ZCMD) CN $0.029B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.021B 0.00
Bullfrog AI Holdings (BFRG) US $0.017B 0.00
MSP Recovery (MSPR) US $0.016B 0.00
Streamline Health Solutions (STRM) US $0.013B 0.00
Healthcare Triangle (HCTI) US $0.012B 0.00
Strata Skin Sciences (SSKN) US $0.011B 0.00
Predictive Oncology (POAI) US $0.010B 0.00
Precipio (PRPO) US $0.010B 0.00
Movano (MOVE) US $0.006B 0.00
Mobile-health Network Solutions (MNDR) SG $0.004B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Tivic Health Systems (TIVC) US $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00